Herceptin breast cancer drug molecule

Herceptin breast cancer drug molecule

F001/0148 Rights Managed

Request low-res file

530 pixels on longest edge, unwatermarked

Request/Download high-res file

Price image Pricing

Please login to use the price calculator


Credit: PASIEKA/SCIENCE PHOTO LIBRARY ***** PHOTO TRANSFERRED TO A617/263 *****

Caption: Herceptin breast cancer drug. Molecular model of Herceptin (Trastuzumab), showing the molecule's secondary structure, seen as alpha helices (coils), beta sheets (arrows). Herceptin binds to HER2 (human epidermal growth factor receptor 2), a cell receptor that is over-expressed in some breast cancer cells, making them grow faster and more likely to spread. Herceptin blocks HER2, which kills the breast cancer cells. Around a fifth of breast cancers result from cells that over-express HER2, making them viable for Herceptin treatment.

Release details: Model release not available. Property release not available.

Keywords:

Licence fees: A licence fee will be charged for any media (low or high resolution) used in your project.